Analyst Ratings for VBI Vaccines (VBIV)
VBIV Rating Summary
VBIV Price Target Summary
- Highest: $8.00 (Oppenheimer)
- Lowest: $6.00 (Raymond James)
- Average: $6.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.67 (+675.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$6.67 (+675.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/29/2021 | Jefferies | Roger Song | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.31 (0.86) |
-62.77% | Details |
| 8/27/2020 | Raymond James » Updated 3/8/2022 |
Steven Seedhouse | Upgrade | Strong Buy (Outperform) |
6.00 (9.00) |
3.28 (0.86) |
-73.78% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
